Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Malformations | 12 | 2025 | 103 | 2.930 |
Why?
|
| Lymphatic Abnormalities | 5 | 2022 | 35 | 2.230 |
Why?
|
| Hemangioma | 8 | 2024 | 86 | 2.090 |
Why?
|
| Sirolimus | 9 | 2024 | 230 | 1.550 |
Why?
|
| Hemangioendothelioma | 4 | 2020 | 24 | 1.310 |
Why?
|
| Kasabach-Merritt Syndrome | 3 | 2020 | 15 | 1.170 |
Why?
|
| Sarcoma, Kaposi | 3 | 2020 | 129 | 1.060 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2021 | 123 | 0.880 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2024 | 8 | 0.860 |
Why?
|
| Lymphangioma | 2 | 2021 | 21 | 0.830 |
Why?
|
| Chylothorax | 2 | 2021 | 27 | 0.830 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2023 | 51 | 0.750 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 47 | 0.750 |
Why?
|
| Osteolysis, Essential | 1 | 2021 | 3 | 0.680 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 21 | 0.670 |
Why?
|
| Pleural Effusion | 1 | 2021 | 103 | 0.660 |
Why?
|
| Vascular Neoplasms | 1 | 2020 | 31 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 1295 | 0.610 |
Why?
|
| Arteriovenous Malformations | 3 | 2024 | 49 | 0.560 |
Why?
|
| Embolization, Therapeutic | 3 | 2024 | 233 | 0.460 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 28 | 0.430 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 909 | 0.390 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 1373 | 0.390 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 2 | 2023 | 6 | 0.380 |
Why?
|
| Child | 22 | 2025 | 26341 | 0.360 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2011 | 23 | 0.330 |
Why?
|
| Lymphatic Vessels | 2 | 2021 | 31 | 0.320 |
Why?
|
| Upper Extremity | 1 | 2011 | 53 | 0.320 |
Why?
|
| Humans | 42 | 2025 | 131163 | 0.310 |
Why?
|
| Blood Vessels | 1 | 2010 | 92 | 0.310 |
Why?
|
| Infant | 15 | 2025 | 13352 | 0.310 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 83 | 0.300 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 157 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 197 | 0.290 |
Why?
|
| Infant, Newborn | 10 | 2024 | 8635 | 0.270 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 223 | 0.270 |
Why?
|
| Drainage | 2 | 2021 | 250 | 0.270 |
Why?
|
| Neutropenia | 2 | 2020 | 209 | 0.270 |
Why?
|
| Ascites | 2 | 2018 | 99 | 0.260 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 227 | 0.240 |
Why?
|
| Congenital Abnormalities | 1 | 2010 | 330 | 0.240 |
Why?
|
| Proteus Syndrome | 1 | 2025 | 1 | 0.230 |
Why?
|
| Splenic Vein | 1 | 2025 | 10 | 0.220 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 77 | 0.220 |
Why?
|
| Splenic Artery | 1 | 2025 | 22 | 0.220 |
Why?
|
| Splenectomy | 1 | 2025 | 61 | 0.210 |
Why?
|
| Epistaxis | 1 | 2024 | 11 | 0.210 |
Why?
|
| Lymphatic System | 2 | 2021 | 18 | 0.210 |
Why?
|
| Spleen | 1 | 2025 | 258 | 0.200 |
Why?
|
| Purpura | 1 | 2023 | 25 | 0.200 |
Why?
|
| Arteriovenous Fistula | 1 | 2023 | 54 | 0.190 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2022 | 37 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2024 | 283 | 0.190 |
Why?
|
| Child, Preschool | 9 | 2025 | 15110 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 67 | 0.180 |
Why?
|
| Octreotide | 1 | 2021 | 23 | 0.180 |
Why?
|
| Retrospective Studies | 11 | 2025 | 17753 | 0.180 |
Why?
|
| Lymphedema | 1 | 2021 | 18 | 0.170 |
Why?
|
| Otolaryngology | 1 | 2023 | 118 | 0.170 |
Why?
|
| Angiomatosis | 1 | 2021 | 5 | 0.170 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 28 | 0.170 |
Why?
|
| Rhabdomyoma | 1 | 2021 | 15 | 0.160 |
Why?
|
| Vascular Diseases | 1 | 2022 | 146 | 0.160 |
Why?
|
| Hemangioma, Capillary | 1 | 2020 | 19 | 0.160 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2020 | 43 | 0.150 |
Why?
|
| Male | 17 | 2025 | 64957 | 0.150 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 46 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2021 | 106 | 0.150 |
Why?
|
| Accelerated Idioventricular Rhythm | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ethiodized Oil | 1 | 2019 | 4 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2020 | 88 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 81 | 0.150 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2019 | 21 | 0.150 |
Why?
|
| Thrombosis | 1 | 2023 | 499 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 252 | 0.140 |
Why?
|
| Peritoneovenous Shunt | 1 | 2018 | 4 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 612 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 157 | 0.140 |
Why?
|
| Chylous Ascites | 1 | 2017 | 9 | 0.130 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 187 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2024 | 1106 | 0.130 |
Why?
|
| Female | 14 | 2025 | 70963 | 0.130 |
Why?
|
| Prognosis | 4 | 2020 | 4886 | 0.130 |
Why?
|
| Critical Illness | 1 | 2021 | 630 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 241 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 305 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 986 | 0.130 |
Why?
|
| Consensus | 1 | 2019 | 512 | 0.130 |
Why?
|
| Thrombocytosis | 1 | 2017 | 34 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 663 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1590 | 0.120 |
Why?
|
| Medical Oncology | 1 | 2018 | 245 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 103 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 210 | 0.120 |
Why?
|
| Anemia | 1 | 2020 | 354 | 0.120 |
Why?
|
| Mutation | 4 | 2025 | 6099 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 597 | 0.110 |
Why?
|
| Young Adult | 4 | 2025 | 10103 | 0.110 |
Why?
|
| Iron Chelating Agents | 1 | 2014 | 15 | 0.110 |
Why?
|
| Iron Overload | 1 | 2014 | 18 | 0.110 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 42 | 0.110 |
Why?
|
| Adolescent | 9 | 2025 | 20987 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 109 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1282 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2020 | 712 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 822 | 0.090 |
Why?
|
| Registries | 1 | 2018 | 1634 | 0.080 |
Why?
|
| Lymphoma | 1 | 2014 | 327 | 0.080 |
Why?
|
| Leukemia | 1 | 2014 | 387 | 0.080 |
Why?
|
| Radiology, Interventional | 2 | 2022 | 31 | 0.080 |
Why?
|
| Algorithms | 2 | 2025 | 1680 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 7512 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 55 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3147 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3763 | 0.080 |
Why?
|
| Administration, Oral | 1 | 2011 | 711 | 0.070 |
Why?
|
| Pediatrics | 1 | 2018 | 1252 | 0.070 |
Why?
|
| Adult | 4 | 2025 | 31282 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2010 | 238 | 0.070 |
Why?
|
| src Homology Domains | 1 | 2007 | 34 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2007 | 41 | 0.060 |
Why?
|
| United States | 2 | 2023 | 12072 | 0.060 |
Why?
|
| Connexins | 1 | 2007 | 63 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2023 | 12936 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2023 | 1882 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 4497 | 0.060 |
Why?
|
| Splenic Diseases | 1 | 2025 | 28 | 0.050 |
Why?
|
| Aminopyridines | 1 | 2025 | 66 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2024 | 22 | 0.050 |
Why?
|
| Imidazoles | 1 | 2025 | 219 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2023 | 106 | 0.050 |
Why?
|
| Propranolol | 1 | 2023 | 110 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2022 | 7 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2022 | 30 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 619 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2465 | 0.050 |
Why?
|
| Capillaries | 1 | 2022 | 63 | 0.050 |
Why?
|
| Sclerotherapy | 1 | 2022 | 36 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1928 | 0.050 |
Why?
|
| Urogenital Abnormalities | 1 | 2024 | 155 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2023 | 216 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 189 | 0.040 |
Why?
|
| Syndrome | 1 | 2024 | 1155 | 0.040 |
Why?
|
| Endothelium, Lymphatic | 1 | 2021 | 10 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2020 | 19 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 354 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2020 | 32 | 0.040 |
Why?
|
| Cysts | 1 | 2020 | 80 | 0.040 |
Why?
|
| Vomiting | 1 | 2020 | 103 | 0.040 |
Why?
|
| Fatigue | 1 | 2020 | 191 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 963 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 808 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5196 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2018 | 108 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2010 | 4686 | 0.030 |
Why?
|
| Peritoneum | 1 | 2017 | 34 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 312 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 159 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2019 | 213 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 2121 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2017 | 46 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 205 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 146 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2825 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 2014 | 3 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 474 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2020 | 807 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3829 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2595 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 263 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4066 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2082 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1559 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6459 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3175 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 33912 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3436 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3061 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1147 | 0.020 |
Why?
|
| Discs Large Homolog 1 Protein | 1 | 2007 | 9 | 0.020 |
Why?
|
| Guanylate Kinases | 1 | 2007 | 18 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 366 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2007 | 594 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 484 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 11074 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3748 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18301 | 0.000 |
Why?
|